Here are four key points:
1. Integra alleges that HyperBranch’s Adherus Autospray Dural Sealant, Adherus Dural Sealant and Adherus Spinal Sealant all infringe patents licensed by Integra from Incept.
2. Integra’s suit claims that U.S. Patents 7,009,034; 7,592,418; 7,332,566; 6,566,406; 8,003,705; and 8,535,705 are infringed by HyperBranch’s Adherus products.
3. The lawsuit is seeking for HyperBranch to discontinue making, selling or offering to sell the Adherus products.
4. Integra is also seeking grant treble damages for willful infringement.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. David Fardon of Rush University Medical Center
Comprehensive Orthopaedic Global welcomes Dr. G. Adam Flowers — 5 facts
Integra LifeSciences receives ‘hold’ rating — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.